1-4 of 4
James C. Lynch, PhD
Close
Sort by
Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation (NST) for Hematologic Malignancies (HM) Using Pentostatin/Low-Dose Total Body Irradiation (TBI).

R. Gregory Bociek, MD, MSc, James E. Talmadge, PhD, James C. Lynch, PhD, Charles A. Enke, MD, Charles A. Kuszynski, PhD, Philip J. Bierman, MD, Julie M. Vose, MD, James O. Armitage, MD, Marcel P. Devetten, MD, Lori J. Maness, MD, Timothy R. McGuire, PhD, James L. Wisecarver, MD, Shantaram S. Joshi, PhD, Zivko S. Pavletic, MD
Journal: Blood
Blood (2005) 106 (11): 3671.
https://doi.org/10.1182/blood.V106.11.3671.3671
Published: 2005
Journal Articles

Differential Expression of Hem1 and CTLA-4 in B-CLL Patients with High and Low CD38 Expression.

Avadhut D. Joshi, B.Pharm, John D. Dickinson, PhD, James C. Lynch, PhD, Philip J. Bierman, MD, Gregory R. Bociek, MD, Marcel P. Devetten, MD, James O. Armitage, MD, Shantaram S. Joshi, PhD
Journal: Blood
Blood (2005) 106 (11): 2103.
https://doi.org/10.1182/blood.V106.11.2103.2103
Published: 2005
Journal Articles

Factors Affecting the Development of Atrial Fibrillation and Atrial Flutter (AF) Following Autologous Hematopoietic Stem Cell Transplantation (auto-HSCT).

Mary Lee H. Villanueva, MD, Fausto R. Loberiza, MD, MS, James O. Armitage, MD, Robert G. Bociek, MD, Apar Kishor Ganti, MD, James C. Lynch, PhD, Farhan Majeed, MD, Stefano R. Tarantolo, MD, Jo Torrey, RN, BSN, Julie M. Vose, MD, Philip J. Bierman, MD
Journal: Blood
Blood (2005) 106 (11): 1754.
https://doi.org/10.1182/blood.V106.11.1754.1754
Published: 2005
Journal Articles

Autologous Transplant Event-Free Survival (EFS) Following Failure of CHOP-Rituximab (CHOP-R) for Diffuse Large B-Cell Lymphoma (DLBCL) Is the Same as the EFS Following Failure of CHOP Alone.

Julie M. Vose, MD, Philip J. Bierman, MD, James C. Lynch, PhD, Gregory Bociek, MD, James O. Armitage, MD
Journal: Blood
Blood (2004) 104 (11): 890.
https://doi.org/10.1182/blood.V104.11.890.890
Published: 2004